Skip to main navigation Skip to search Skip to main content

Investigation of enhancer structure activity relationships in congeners of 2-(1-nonyl)-1,3-dioxolane

Research output: Contribution to journal › Article › peer-review

Abstract

Twelve analogues of 2-(1-nonyl)-1,3-dioxolane were examined for enhancer activity using occluded hairless mouse skin in vitro with hydrocortisone as the model drug. Controls consisted of no enhancer or vehicle pretreatment (I) or propylene glycol pretreatment 1 h prior to drug application (II). Enhancers were applied at 0.4 M in propylene glycol (PG) 1 h prior to skin application of a saturated suspension of hydrocortisone in the same vehicle. The highest 24-h receptor concentration (Q24) of steroid was observed using 2-(1-nonyl)-1,3-dioxolane: 131.472 ± 20.659 μM compared to Control I of 16.462 ± 4.859 Rm. Control II Q24 values were 34.015 ± 9.959 μm. The highest skin steroid content was produced by 2-(1-nonyl)-2-methyl-1,3-dioxolane: 431.4 ± 212.2 μg g-1 and 2-(1-nonyl)-2,4-dimethyl-1,3-dioxolane: 385.7 ± 138.7 μg g-1. Skin steroid content of Control I was 490.2 ± 243.2 μg g-1 and of II was 112.7 ± 31.3 μg g-1. Control I and II results indicated that PG was exhibiting enhancer activity. All 12 dioxolanes showed poor skin steroid retention (compared with Control I), suggesting that these compounds could be useful for enhancing systemic rather than local drug delivery.

Original languageEnglish (US)
Pages (from-to)117-122
Number of pages6
JournalDrug delivery
Volume2
Issue number2
DOIs
StatePublished - 1995
Externally publishedYes

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Investigation of enhancer structure activity relationships in congeners of 2-(1-nonyl)-1,3-dioxolane'. Together they form a unique fingerprint.

Cite this